New guidelines for the management of norovirus outbreaks in acute and community health and social care settings
|
|
- Brittney Maxwell
- 6 years ago
- Views:
Transcription
1 Volume 5 Number 47 Published on: 25 November 2011 Current News New guidelines for the management of norovirus outbreaks in acute and community health and social care settings Surveillance of haemolytic uraemic syndrome in children Measles cases in Europe: update to end-october 2011 Infection Reports Immunisation Laboratory confirmed cases of measles, mumps and rubella, England and Wales: July to September 2011 Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme during April to June 2011
2 News Volume 5 Number 47 Published on: 25 November 2011 New guidelines for the management of norovirus outbreaks in acute and community health and social care settings A new report on the management of outbreaks of vomiting and/or diarrhoea in hospitals, and in other community health and social care settings, aims to achieve a balance between the prevention of spread of infection and the need to minimise disruption of services while outbreak control measures are in place [1]. Developed following a Department of Health workshop held in July 2010, the title of the guidance reflects the fact that, while there are other causes of vomiting and/or diarrhoea outbreaks (and its recommendations will therefore apply to all viral gastroenteritides), the principal and most common cause is norovirus, which is one of the most infective agents seen in health and social care establishments [2]. The guidance, published on the HPA website [3], was developed by a multi-agency working party (the members of which acted as representatives of their respective organisations) and involved a number of stakeholder consultation exercises [4]. There was also the full involvement of NHS management representation through the NHS Confederation. It is therefore anticipated that the resulting joint ownership of the guidance between infection prevention and control (IPC) practitioners on the one hand, and the managerial sector on the other, will reduce conflicts of interest and tensions within organisations. This is important because, an introduction/methodology section of the guidance notes, differing patterns and dynamics of outbreaks will require different, tailored IPC responses which may be misconstrued as inconsistency of approach and it is, therefore, important that the underlying principles are understood by all sections and levels of an affected organisation. The introduction continues: This guidance is based on a principle of minimising the disruption to important and essential services and maximising the ability of organisations to deliver appropriate care to patients safely and effectively. There is a shift of focus towards a balance between the prevention of spread of infection and maintaining organisational activity. In effect, this means a move away from the traditional approach of early, complete ward closure and an adoption of a pragmatic, escalatory system of isolation using single rooms and cohort nursing without compromising patient care both for norovirus itself and other essential healthcare. This is a key difference to previous guidance of the Public Health Laboratory Service Working Party published in The guidance draws on current practice that shows that cases should be managed in single rooms and bays in the first instance if this is possible. This will allow some flexibility in the response and also for cleaning to take place allowing smaller wards to be able to re-open more quickly. Other recommendations cover closure of affected bays to admissions/transfers, use of signage, restriction of access to affected areas, deep cleaning, etc. There are separate recommendations for healthcare workers in outbreak situations, including the need to ensure staff are aware of work exclusion policy, the need for staff to be allocated staff to duties in either affected or non-affected areas but not both, etc.
3 References 1. "New guidelines for the management of norovirus". HPA press release, 25 November The guidance applies to nursing and residential homes. It is not specifically intended to cover schools, colleges, prisons, military establishments, hotels or shipping but it enshrines generalisable principles that will be of use in managing outbreaks in those institutions. 3. Guidelines for the management of norovirus outbreaks in acute and community health and social care settings, November 2011 [1.2 MB PDF]. Downloadable from the HPA website: Home Publications Infectious diseases Infection control. 4. The working party comprised representatives of the following organisations: the HPA; the NHS Confederation; the British Infection Association; the Healthcare Infection Society; the Infection Prevention Society; the Sowerby Centre for Health Informatics Newcastle; and National Concern for Healthcare Infections. Observers from UK departments of health and the Community Care Sector also participated. Other external stakeholders are listed in an appendix to the guidance. Surveillance of haemolytic uraemic syndrome in children A study aiming to better define the incidence of haemolytic uraemic syndrome (HUS) in children in the UK and Ireland has been jointly launched by the British Paediatric Surveillance Unit (BPSU) and HPA. The study also involving paediatric nephrologists and public health bodies in the Devolved Administrations and the Republic of Ireland will provide valuable data on the incidence of HUS, clinical progression and management of cases, and outcomes of disease one year after presentation. By linking incidence, exposure and clinical data with laboratory reports, the study aims to determine which strains of VTEC are causing HUS. The results will be compared with those of a previous BPSU-HUS study ( ) to allow changes in epidemiology and any necessary changes to clinical management to be determined. HUS is a rare but serious condition that can develop following diarrhoeal illness caused by vero cytotoxin-producing Escherichia coli (VTEC). The peak incidence of HUS is in children under five of age. Patients generally develop HUS a week or more after their symptoms have disappeared, by which time they present a minimal risk to other people, which means the previous regular connection with the HPA may have ceased. Cases of HUS are therefore not often identified through the existing VTEC enhanced surveillance system for England. HUS was included in the notifiable disease list (Schedule 1) of the Health Protection (Notification) Regulations However, it is known that data collected through the Notifications of Infectious Disease system is incomplete and this study will allow a more complete understanding of the epidemiology of the disease. Clinicians in England, Wales, Northern Ireland and the Republic of Ireland will be asked to report cases of HUS under the age of 16 through the BPSU. Scottish clinicians will continue to report through the existing HUS surveillance system run by Health Protection Scotland, and data from this system will be included in the study. The study will run for 13 months with a one year follow-up questionnaire. Together with the national surveillance system for VTEC, data collected will help identify factors associated with an increased risk of developing HUS, in the hope that, in the future, it may be possible to prevent at-risk children from developing HUS after a VTEC infection. Further information is available at: VTEC@hpa.org.uk.
4 Measles cases in Europe: update to end-october 2011 The fifth European monthly measles monitoring (EMMO) surveillance report has been published by the European Centre for Disease Prevention and Prevention (ECDC) [1]. Although no new outbreaks were reported in the 29 EU and EEA/EFTA countries during October, over 1,000 new measles cases were detected through epidemic intelligence, bringing the total number of cases for 2011 to more than 30,200. Two cases of sub-acute sclerosing panencephalitis (SSPE), one of whom died, were reported in October. Between January and September eight measles-related deaths and 23 cases of acute measles encephalitis were reported. WHO Regional Office for Europe published it's Epidemiological Brief in October covering the measles outbreaks and preventative measures taken across 53 member countries [2]. The report highlights the nearly three-fold increase in cases compared to the same period in The wider impact of the outbreaks in Europe was also examined and in particular the link between the resurgence in measles in South America and its connection with Europe. Confirmed measles cases in England and Wales to the end of October 2011 In England and Wales, 956 laboratory confirmed measles cases have been reported to the end of October 2011 (see table 1 and figure). Following the peak in April 2011, the monthly total of confirmed cases has been falling with between 53 and 68 confirmed cases reported in the last three months. The majority of cases are in unvaccinated individuals (92% total). Outbreaks in schools and small family clusters are continuing to occur, particularly in London (401 cases) and the South (255 cases) regions where most cases have been diagnosed. A history of travel abroad or contact with someone who had travelled was the source for infection for 150 confirmed cases this year. Table 1. Confirmed cases of measles by region and month of onset, England and Wales: January-October 2011 Month London Mids of England North North South South Mids Wales York & Humber Jan Feb Mar Apr May Jun Jul Aug Sep Oct Total Total to October
5 Table 2. Number of confirmed cases of measles by region and age, England and Wales: January-October 2011 Month London Mids of England North North South South Mids Wales York & Humber Total Under 1 year Total, all age groups Number of confirmed measles cases by month of onset, England and Wales: January 2006 to October 2011 References 1. European Centre for Disease Prevention and Control (ECDC). European measles monthly monitoring, October Stockholm: ECDC; Available from: 2. World Health Organisation, Regional Office for Europe (WHO Europe). WHO Epidemiological Brief: a monthly publication on vaccine-prevantable diseases and immunisation data and analysis, No.18 (October 2011). Available from: data/assets/pdf_file/0006/153195/epi_brief_issue_18.pdf.
6 Infection reports Volume 4 Number 47 Published on: 25 November 2011 Immunisation Laboratory confirmed cases of measles, mumps and rubella, England and Wales: July to September 2011 Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme during April to June 2011 Laboratory confirmed cases of measles, mumps and rubella, England and Wales: July to September 2011 Data presented here are for the third quarter of 2011 (ie July to September 2011). Cases include those confirmed by oral fluid testing (IgM antibody tests and/or PCR) at the Virus Reference Department, Colindale and national routine laboratory reports (table 1). Analyses are by date of onset. Regional breakdown figures relate to Government Office Regions rather than regional health authorities (pre-april 2002 definitions). Quarterly figures for cases confirmed by oral fluid antibody detection only from 1995 and annual total numbers of confirmed cases by health region and age are available from: Table 1 Total confirmed cases of measles, mumps and rubella, and oral fluid IgM antibody tests in notified cases: weeks 27-39/2011 Cases reported to Health Protection Units in England* Notified cases in England and Wales Number tested % of notified cases tested Oral fluid testing Total positive Recently vaccinated Confirmed cases Confirmed infections Other samples Total Measles * Mumps Rubella * This figure represents the number of infections reported as possible cases and investigated by individual HPUs in England.
7 Measles There were 212 cases of measles confirmed with onset dates in the third quarter of 2011, compared to 472 cases in the previous quarter [1]. As in the previous quarter, the majority of cases identified between July and September were in London (124 cases, 59%), although all regions in England and Wales reported cases (see table 1, news item this week). Clusters in schools and communities in London (number of affected individuals ranging between 2 and 25) accounted for the increased level of reporting in this region. The majority (165/212, 77%) of the confirmed cases this quarter were in children and adolescents: 12 (6%) under one year; 43 (20%) aged 1 to 4 ; 40 (19%) aged 5 to 9 year, 37 (17%) aged 10 to 14 ; 33 (16%) aged 15 to 18. The remaining 47 (22%) cases were aged 19 to 46. Less than four percent (8/212 cases) of the confirmed measles cases reported receiving one dose of a measles containing vaccine although only 5 (2%) were confirmed based on GP records. A history of recent travel to Europe continued to be a source of infection with 22 cases (10%) known to have acquired their infection abroad: Italy (five cases), France (three cases), Greece (two cases), Ireland (two cases), Romania (two cases) and in Kenya, Georgia, Poland, Belgium, Spain, Cyprus, Switzerland and US (one case each). Mumps There were 335 laboratory confirmed cases of mumps with onset in the third quarter reported compared to 799 in the previous quarter [1]. Cases continue to occur predominantly in individuals born between 1980 and 1990 (see figure), many of whom either were not routinely offered MMR vaccination in childhood, or have only received one dose. The majority of reports were from the London, South and North regions although cases were identified in all regions of England and Wales (table 2). Table 2: Confirmed cases of mumps by age group and region, England and Wales: weeks 27-39/2011 Region < Total North North Yorks & Humber Midlands Midlands of England London South South Wales Total
8 Distribution (as a percentage of total number) of laboratory confirmed mumps cases in England and Wales by year of birth and quarter Rubella Three cases of rubella were confirmed this quarter, compared to a single case the previous quarter [1]. These were aged between and all three cases were born outside the UK. Only one case reported a history of recent travel. Reference 1. HPA. Laboratory confirmed cases of measles, mumps and rubella, England and Wales: April to June Health Protection Report HPR 2011; 4(34): immunisation. Available at:
9 Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme during April to June 2011 There were 211 laboratory confirmed cases of pertussis (culture, PCR, serology) reported to the pertussis enhanced surveillance programme in the second quarter of 2011 (see table). This is double the number of cases reported in the previous quarter (106 in January to March 2011 [1]). Cases reported in the second quarter of 2011 are higher than the same quarter last year (104 cases between April and June 2010 see figure). This is consistent with increased levels of pertussis activity observed in some areas and fits the recognised epidemiological pattern of 3-4 yearly cyclical peaks in pertussis, with the last peak occurring in Laboratory-confirmed cases of pertussis by age and testing method, England and Wales, April to June 2011 Age group Culture tested PCR tested Serology tested <3 months months months Age not known 1 1 All ages Total number of laboratory-confirmed cases of pertussis per evaluation quarter in England and Wales since 2005
10 There has been a background increase in laboratory confirmed cases, largely in older age groups, subsequent to the introduction of new laboratory methods in More detailed explanations were provided in previous HPR articles [2]. Although a greater number of notified cases are being confirmed in older age groups, rates of confirmed cases in these age groups remain relatively low [2]. Bordetella pertussis PCR (for hospitalised cases <1 year old) and serological investigation by estimation of anti-pertussis toxin (PT) IgG antibody levels for older children and adults are provided by the Respiratory and Systemic Infection Laboratory (RSIL) at the HPA Microbiology Services Division Colindale. The laboratory also encourages submission of all Bordetella pertussis isolates for confirmation and national surveillance purposes. Further information is available on the HPA website at References 1. HPA. Laboratory-confirmed cases of pertussis reported to the enhanced surveillance programme, England and Wales: January to March Health Protection Report 2011; 4(34): immunisation. Published on: 26 August Available at: 2. HPA. Laboratory-confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in Health Protection Report 2010; 4(25): immunisation. Available at:
Measles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
More informationEuropean monthly measles monitoring (EMMO)
SURVEILLANCE REPORT European monthly measles monitoring (EMMO) Issue 9: 19 March 2012 Main developments In January 2012, 584 cases of measles were reported by the 29 contributing EU and EEA countries.
More informationGlobal and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.
Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationMeasles, Mumps, Rubella (MMR) Vaccine discussion pack. an information guide for health professionals and parents
Measles, Mumps, Rubella (MMR) Vaccine discussion pack an information guide for health professionals and parents The MMR discussion pack an information guide for health professionals and parents Published
More informationMeasles: United States, January 1 through June 10, 2011
Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA
More informationNHS public health functions agreement Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme
NHS public health functions agreement 2018-19 Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme 1 NHS public health functions agreement 2018-19 Service specification
More informationSession 1. The aims of immunisation, national policy and schedules. Quality Education for a Healthier Scotland
Session 1 The aims of immunisation, national policy and schedules Aim The aim of this session is to explain the aims of immunisation, and describe national policy and schedules Learning Outcomes At the
More informationEUVAC.NET A surveillance network for vaccine-preventable diseases
EUVAC.NET A surveillance network for vaccine-preventable diseases Mark Muscat EUVAC.NET Co-ordinator Department of Epidemiology Statens Serum Institut Denmark Email: mmc@ssi.dk Viral Hepatitis Prevention
More informationIbrahim Abubakar, MBBS, MSc, PhD, FFPH
Ibrahim Abubakar, MBBS, MSc, PhD, FFPH Head of Section / Consultant Epidemiologist Tuberculosis Section HPA Centre for Infections Colindale London UK Outline TB epidemiological situation UK data collection
More informationMeasles in Ireland, 2005
Measles in Ireland, 2005 Key Points There were 93 measles notifications in 2005 The crude incidence rate of measles per 100,000 population in 2005 was 2.4 compared to 8.4 in 2004 and 14.6 in 2003 Of the
More informationQuality & Safety Committee Date: 22 June 2016 Agenda item: 4.4
SUMMARY REPORT ABM University Health Board Quality & Safety Committee Date: 22 June 20 Agenda item: 4.4 Subject Prepared by Approved by Infection Prevention & Control Delyth Davies, Head of Nursing, Infection
More informationMeasles Elimination Dr. Suzanne Cotter 4 th National Immunisation Conference 2007
Measles Elimination 2010 Dr. Suzanne Cotter 4 th National Immunisation Conference 2007 Measles Viral illness Highly infectious Human reservoir only Respiratory transmission Responsible for ~500,000 deaths
More informationGastrointestinal Infections in Northern Ireland
Gastrointestinal Infections in Northern Ireland Annual Surveillance Report 214 Gastrointestinal Infections in Northern Ireland Annual Surveillance Report 214 Contents Key Points...1 Introduction...2 Food
More informationMidland infectious disease activity summary (MIDAS), Vol 1 (9), Oct 09
Midland infectious disease activity summary (MIDAS), Vol 1 (9), Oct 09 Item Type Other Authors Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Publisher Health Service Executive (HSE) Dublin/Mid-Leinster
More information8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )
8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 213 (covering week 33 213) Current level of activity: Low Trend: Stable compared to last week News: Update Middle East
More informationMumps in the Community Dr. Isabel Oliver, A Webber Training Teleclass
Overview MUMPS in the Community Dr. Isabel Oliver Consultant Regional Epidemiologist HPA South West Isabel.oliver@hpa.org.uk www.webbertraining.com The Health Protection Agency Mumps Control of mumps Epidemiology
More informationNHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11
NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11 NHS GRAMPIAN IMMUNISATION STEERING GROUP March 2012 1 Table of Content 1. Purpose of this report.3 2. Uptake of immunisation: key points during
More informationWeekly Influenza Surveillance Report. Week 11
Weekly Influenza Surveillance Report Week 11 Report produced: 22/03/2001 Influenza activity in Ireland For the week ending the 18/03/01, week 11, influenza activity has increased. Sentinel general practices
More informationThe State of Measles and Rubella in the WHO European Region
The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual
More informationClassification: official 1
NHS public health functions agreement 2018-19 Service specification No.4 Immunisation against diphtheria, tetanus, poliomyelitis, pertussis, Hib and HepB programme 1 NHS public health functions agreement
More informationGastrointestinal Infections in Northern Ireland
Gastrointestinal Infections in Northern Ireland Annual Surveillance Report 213 Gastrointestinal Infections in Northern Ireland Annual Surveillance Report 213 Contents Key Points...1 Introduction...2 Food
More informationNYS Trends in Vaccine Preventable Disease Control
NYS Trends in Vaccine Preventable Disease Control Cindy Schulte, BSN, RN Bureau of Immunization 518-473-4437 crs01@health.state.ny.us 1 Objectives Participants will be able to identify disease outbreaks
More information3. Title Vaccination and immunisation data return collected through the COVER
1. Record Type? 2. Unique Number Reassessment R00019 3. Title Vaccination and immunisation data return collected through the COVER 4. Collection Type National 5. Other Reference 6. Description Cover of
More informationPublic Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 2015 (covering week )
The The Influenza B in certain countries8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 215 (covering week 3 215) Current level of activity: Low Trend: Decreased
More informationVII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7
VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE IMMUNISATION PROGRAMME IN 2002 7. 7 The childhood immunisation programme in Singapore offers vaccination against tuberculosis, hepatitis B, diphtheria,
More informationNHS public health functions agreement Service specification No.5 Rotavirus immunisation programme
NHS public health functions agreement 2018-19 Service specification No.5 Rotavirus immunisation programme Classification: official 1 NHS public health functions agreement 2018-19 Service specification
More information1. INTRODUCTION. 1.1 Standard Precautions
1. INTRODUCTION 1.1 Standard Precautions Standard precautions, originally known as universal precautions, are essential components in preventing the transmission of infectious diseases in the healthcare
More informationPneumococcal polysaccharide vaccine uptake in England, , prior to the introduction of a vaccination programme for older adults
Journal of Public Health Advance Access published July 7, 2006 Journal of Public Health pp. 1 of 6 doi:10.1093/pubmed/fdl017 Pneumococcal polysaccharide vaccine uptake in England, 1989 2003, prior to the
More informationA report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%
% of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected
More informationNSW Annual Vaccine-Preventable Disease Report, 2011
NSW Annual Vaccine-Preventable Disease Report, 211 Alexander Rosewell A,B, Paula J. Spokes A and Robin E. Gilmour A A Health Protection NSW B Corresponding author. Email: arosw@doh.health.nsw.gov.au Abstract:
More informationHospital Norovirus Outbreak Reporting
Second Report of the Health Protection Agency. Hospital Norovirus Outbreak Reporting Summary findings In January 2009 the HPA in conjunction with the Infection Prevention Society launched a voluntary National
More informationVaccine hesitancy in the EU: state of play and impact on vaccination programmes
Vaccine hesitancy in the EU: state of play and impact on vaccination programmes Lucia PASTORE CELENTANO, MD, MSc Head of the Vaccine Preventable Diseases Programme, ECDC Addressing vaccine hesitancy in
More informationResearch Article Epidemiological Patterns of Varicella in the Period of 1977 to 2012 in the Rijeka District, Croatia
Epidemiology Research International, Article ID 193678, 4 pages http://dx.doi.org/1.1155/214/193678 Research Article Epidemiological Patterns of Varicella in the Period of 1977 to 212 in the Rijeka District,
More informationImmunisation Update for Occupational Health
Immunisation Update for Occupational Health Dr Gayatri Amirthalingam Immunisation, Hepatitis & Blood Safety department Public Health England 29 th April 2016 Session Outline Epidemiology of vaccine preventable
More informationTeenage Booster Immunisation Statistics
Publication Report Teenage Booster Immunisation Statistics Teenage Td/IPV booster and teenage MenC booster immunisation uptake rates for school year 2013/14 Publication date 16 December 2014 An Official
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationPRIMARY CARE CO-COMMISSIONING COMMITTEE. 9 June 2015
Agenda Item No. 9 Part 1 X Part 2 PRIMARY CARE CO-COMMISSIONING COMMITTEE 9 June 2015 Title of Report National Flu Plan Winter 2015/16 Requirement Summary and Trafford CCG Option Appraisal Purpose of the
More informationHighland NHS Board 6 October 2015 Item 5.1 NEW VACCINATION PROGRAMMES
Highland NHS Board 6 October 2015 Item 5.1 NEW VACCINATION PROGRAMMES Report by Abhayadevi Tissington, Nurse Consultant Health Protection and Ken Oates, Consultant in Public Health on behalf of Hugo Van
More informationTeenage Booster Immunisation Statistics
Publication Report Teenage Booster Immunisation Statistics Teenage Td/IPV booster immunisation uptake rates for school years 2011/12 to 2012/13 Publication date 25 March 2014 An Official Statistics Publication
More informationNSW PUBLIC HEALTH BULLETIN
Vol. 18(7 8) July August 2007 State Health Publication PH 070140 ISSN 1034 7674 NSW PUBLIC HEALTH BULLETIN Year In Review 2006 Year in review: communicable disease surveillance, New South Wales, 2006 Communicable
More informationPertussis immunisation for pregnant women
Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis. Before the introduction
More informationGuidance for the Control of Measles Incidents and Outbreaks in Scotland. Scottish Health Protection Network Scottish Guidance No 4 (2018 edition).
Guidance for the Control of Measles Incidents and Outbreaks in Scotland. Scottish Health Protection Network Scottish Guidance No 4 (2018 edition). Revised September 2018 Document Amendment Log Version
More informationHistory and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8
History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop
More informationVaccines Work Version
Vaccines Work 2018 Version European Immunisation Week (EIW) is celebrated across the European Region every April to raise awareness of the importance of immunisation for people s health and well-being.
More informationEPIET REPORT. Background. Fellowship projects
EPIET REPORT Summary of work activities Denisa Janta European Programme for Intervention Epidemiology Training (EPIET), 2011 cohort Background Pre-fellowship short biography Before joining EPIET, Denisa
More informationAn ongoing large outbreak of measles in Merseyside, England, January to June 2012
Rapid communications An ongoing large outbreak of measles in Merseyside, England, January to June 212 R Vivancos (roberto.vivancos@hpa.org.uk) 1, A Keenan 1, S Farmer 1, J Atkinson 1, E Coffey 2, E Dardamissis
More informationHPV Immunisation Uptake Statistics for the Catch-up Programme
Publication Report HPV Immunisation Uptake Statistics for the Catch-up Programme 1 September 2008 31 August 2011 Publication date 25 September 2012 An Official Statistics Publication for Scotland Contents
More informationNHS public health functions agreement Service specification No. 31 Meningococcal group B (MenB) programme
NHS public health functions agreement 2017-18 Service specification No. 31 Meningococcal group B (MenB) programme Classification: official NHS public health functions agreement 2017-18 Service specification
More informationNHS public health functions agreement
NHS public health functions agreement 2016-17 Service specification No.4 Immunisation against diphtheria, tetanus, poliomyelitis, pertussis and Hib programme Classification: official NHS England INFORMATION
More informationEvaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK
Evaluation of the Health and Social Care Professionals Programme Interim report Prostate Cancer UK July 2014 Contents Executive summary... 2 Summary of the research... 2 Main findings... 2 Lessons learned...
More informationMeasles vaccine: a 27-year follow-up.
Measles vaccine: a 27-year follow-up. Item type Authors Article Ramsay, M E; Moffatt, D; O'Connor, M Citation Measles vaccine: a 27-year follow-up. 1994, 112 (2):409-12 Epidemiol. Infect. Journal Rights
More informationLaboratory confirmed 25%
Introduction The following measles surveillance report covers the year 2004 and aims to describe basic epidemiological features of measles in EUVAC.NET participating countries. All incidence rates are
More informationSurveillance of influenza in Northern Ireland
Surveillance of influenza in Northern Ireland 2012 2013 Contents Summary... 1 Introduction... 2 Sources of data... 2 Sentinel GP surveillance... 2 Out-of-Hours Centres... 2 Virological surveillance...
More informationHighlighting in the WHO European Region:
No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationIf you are not sure if your child is up to date with their MMR, please check with your GP.
Please reply to: Tha Han E-mail: tha.han@enfield.gov.uk Phone: Textphone: Fax: My Ref: Your Ref: Date: 19 th June 2018 Dear Parent(s) / Guardian(s) Measles in Enfield I am writing to tell you that a number
More informationSurveillance of influenza in Northern Ireland: season
Surveillance of influenza in Northern Ireland: 2017 2018 season Contents Introduction... 3 Enhanced influenza surveillance systems... 3 In-hours GP Practice surveillance... 3 GP Out-of-Hours surveillance...
More informationINFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust)
A member of: Association of UK University Hospitals INFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust) IPC20 VACCINATION PROGRAMME FOR STAFF AND
More informationHighlighting in the WHO European Region: Summary. No. 21(February 2012)
No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationNHS public health functions agreement Service specification No.11 Human papillomavirus (HPV) programme
NHS public health functions agreement 2018-19 Service specification No.11 Human papillomavirus (HPV) programme 1 NHS public health functions agreement 2018-19 Service specification No.11 Human papillomavirus
More informationHepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Hepatitis A Key facts In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed. The
More informationChildhood immunisation: An Update
Childhood immunisation: An Update Helen Bedford Senior Lecturer in Children s Health UCL Institute of Child Health h.bedford@ucl.ac.uk June 11 th 2013 Immunisation Part of Healthy Child Programme HVs and
More informationSURVEILLANCE REPORT. Measles and rubella surveillance
SURVEILLANCE REPORT Measles and rubella surveillance - 2017 www.ecdc.europa.eu ECDC SURVEILLANCE REPORT Measles and rubella surveillance - 2017 This report of the European Centre for Disease Prevention
More informationSOP Objective To prevent Healthcare Workers (HCWs) being a possible source of cross-infection to either patients or colleagues.
Page 1 of 11 The most up-to- version of this SOP can be viewed at the following website: SOP Objective To prevent Healthcare Workers (HCWs) being a possible source of cross-infection to either patients
More informationThe schedule for childhood vaccination is:(web link to NHS Childhood Immunisation Schedule for 2008
Immunisations and vaccinations Immunisation is an effective public health intervention for promoting good health and protecting individuals and populations against serious disease and infection through
More informationDisease Surveillance. Soili Larkin & Joshna Mavji
Disease Surveillance Soili Larkin & Joshna Mavji Aim To understand the basic principles of surveillance within the field of health protection 2 Disease Surveillance Learning Objectives Define disease surveillance
More informationAnnual Epidemiological Report
December 2018 Annual Epidemiological Report Key Facts Cryptosporidium 1 infection in Ireland, 2017 In 2017, 589 cases of cryptosporidiosis were notified in Ireland 36 were hospitalised, with no reported
More informationDownloaded from:
Granerod, J; Davison, KL; Ramsay, ME; Crowcroft, NS (26) Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales.
More informationTeenage Booster Immunisation Statistics Scotland
Publication Report Teenage Booster Immunisation Statistics Scotland Teenage Td/IPV booster and teenage Men C booster immunisation uptake rates for school year 2014/15 Publication date 15 December 2015
More informationData Flows for Direct Commissioning v1.54 Activity Reporting Programme Child Immunisations UNIFY Collections: Guidance
Data Flows for Direct Commissioning (COVER) UNIFY Collections: Guidance v1.54 Activity Reporting Programme UNIFY Collections: Guidance Page 1 of 11 (COVER) UNIFY Collections: Guidance This document aims
More informationHas the UK had a double epidemic?
Has the UK had a double epidemic? Dr Rodney P Jones Healthcare Analysis & Forecasting www.hcaf.biz hcaf_rod@yahoo.co.uk Introduction Outbreaks of a new type of epidemic, possibly due to immune manipulation,
More informationPublic Health Wales Vaccine Preventable Disease Programme
Public Health Wales Vaccine Preventable Disease Programme LHB practice level reports Cwm Taf LHB July June August Page of Contents. Purpose and Background.... LHB Summary.... Practice level data Merthyr
More informationTeenage Booster Immunisation Statistics Scotland
Teenage Booster Immunisation Statistics Scotland Uptake for School Year 2017/18 27 November 2018 An Official Statistics publication for Scotland This is an Official Statistics Publication The Official
More informationMeasuring childhood vaccine coverage in England: the role of Child Health Information Systems
Perspectives Measuring childhood vaccine coverage in England: the role of Child Health Information Systems G Amirthalingam (gayatri.amirthalingam@hpa.org.uk) 1, J White 1, M Ramsay 1 1. Immunisation, Hepatitis
More informationEpidemiology of Verotoxigenic E. coli O157 in Ireland, 2003 Patricia Garvey and Paul McKeown
Epidemiology of Verotoxigenic E. coli O157 in Ireland, 2003 Patricia Garvey and Paul McKeown National Disease Surveillance Centre 25-27 Middle Gardiner Street, Dublin 1, Ireland Introduction Verotoxigenic
More informationTRUST WIDE DOCUMENT DOCUMENT NUMBER: ELHT Version 1
i TRUST WIDE DOCUMENT DOCUMENT TITLE: SEASONAL INFLUENZA PLAN DOCUMENT NUMBER: ELHT Version 1 DOCUMENT PURPOSE: Seasonal Influenza (Flu) Plan sets out a coordinated and evidence-based approach to planning
More informationA report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10%
A report on the epidemiology of selected vaccine-preventable diseases in the European Region This report provides an overview of selected epidemiological characteristics of measles and rubella in the WHO
More informationECDC TECHNICAL DOCUMENT. Severe influenza surveillance in Europe
ECDC TECHNICAL DOCUMENT Severe influenza surveillance in Europe Suggested citation: European Centre for Disease Prevention and Control. Severe influenza surveillance in Europe. Stockholm: ECDC; 2012. Stockholm,
More informationRTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
More informationPertussis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Pertussis Key facts In 2016, 48 446 cases of pertussis were reported in 30 EU/EEA countries. Germany, the Netherlands, Poland and the UK accounted
More informationSwine Flu Pandemic Weekly Report Thursday 20 August 2009
Key points Swine Flu Pandemic Weekly Report Thursday 20 August 2009 Levels of flu in Wales have decreased in the week ending 16 August. Current levels of flu in Wales are still higher than usual for this
More informationCommunicable Diseases Report, NSW, March and April 2012
Communicable Diseases Report,, March and April 2 Communicable Diseases Branch Department of Health For updated information, including data and facts on specific diseases, visit www.health.nsw.gov.au and
More informationNational seasonal influenza vaccination programmes in Europe
National seasonal influenza vaccination programmes in Europe Pasi Penttinen, Office of the Chief Scientist European Centre for Disease Prevention and Control (ECDC) Over 90 000 excess deaths among the
More informationMeasles Elimination in NZ. Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health
Measles Elimination in NZ Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health Presentation Outline International background WHO requirements Overview of the measles situation
More informationNHS public health functions agreement Service specification No.12 Td/IPV (teenage booster) immunisation programme
NHS public health functions agreement 2018-19 Service specification No.12 Td/IPV (teenage booster) immunisation programme NHS public health functions agreement 2018-19 Service specification No.12 Td/IPV
More informationReport on Childhood Immunisations in Barnet
Report on Childhood Immunisations in Barnet Summary This paper has been requested to inform Barnet Health and Wellbeing Board about the 7a immunisation programmes currently commissioned by NHS England
More informationSpotlight on measles 2010: Ongoing measles outbreak in Greece, January July 2010
Rapid communications Spotlight on measles 2010: Ongoing measles outbreak in Greece, January July 2010 D Pervanidou (pervanidou@gmail.com) 1, E Horefti 2, S Patrinos 1, T Lytras 1, E Triantafillou 1, A
More informationNSW Annual Vaccine-Preventable Disease Report, 2009
NSW Annual Vaccine-Preventable Disease Report, 29 Paula J. Spokes A,B and Robin E. Gilmour A A Communicable Diseases Branch, NSW Department of Health B Corresponding author. Email: pspok@doh.health.nsw.gov.au
More information19-30 June 2004 UK PRESENTATION ON PREVENTION, INVESTIGATION AND CONTROL OF HUMAN INFECTIOUS DISEASE
19-30 June 2004 BWC MEETING OF EXPERTS JULY 2004: UK PRESENTATION ON PREVENTION, INVESTIGATION AND CONTROL OF HUMAN INFECTIOUS DISEASE Healthcare in the UK: recent organisational changes In the UK, a National
More informationCheshire & Merseyside Health Protection Unit
Cheshire & Merseyside Health Protection Unit HEALTH PROTECTION Epidemiology Report 2009 Health Protection Agency Acknowledgements We would like to acknowledge the contributions and support from the staff
More informationGuidance for obtaining faecal specimens from patients with diarrhoea (Background information)
Guidance for obtaining faecal specimens from patients with diarrhoea (Background information) Version 1.0 Date of Issue: January 2009 Review Date: January 2010 Page 1 of 11 Contents 1. Introduction...
More informationAnnual measles notifications & vaccine coverage England and Wales
Conclusions on MMR vaccine safety by the All-Party Parliamentary Group on Primary Care and Public Health On Monday 24 th July 2000, Dr Elizabeth Miller, Head of the Immunisation Division at the PHLS Communicable
More informationTEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN
TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN Richard Smithson Neil Irvine Maureen McCartney Consultant Health Protection October 2012 Pertussis/whooping cough The disease Whooping Cough
More informationWorld Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006
World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,
More informationMonitoring vaccine-preventable diseases is
New South Wales annual vaccinepreventable disease report, 2013 Surveillance Report Alexander Rosewell, a Paula Spokes a and Robin Gilmour a Correspondence to Robin Gilmour (e-mail: rgilm@doh.health.nsw.gov.au).
More informationHPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011
HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011 Health Protection Surveillance Centre, www.hpsc.ie Version 2.1 October, 2012 Table of Contents Acknowledgements... 3 Key Points... 3 Introduction...
More informationSouth Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member
Agenda item: 9.4 Subject: Presented by: Submitted to: South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member Governing Body Date: 28 th July Purpose of paper:
More informationMEASLES, MUMPS, RUBELLA (MMR)
MEASLES, MUMPS, RUBELLA (MMR) WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST MEASLES, MUMPS OR RUBELLA? GET INFORMED! GET VACCINATED! GET PROTECTED! MMR VACCINE
More informationImmunization-Preventable Outbreaks, Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014
Immunization-Preventable Outbreaks, 2014 Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014 Outbreaks to Cover Meningococcus group B Pertussis Mumps
More information